Structure−Activity Studies Including a Ψ(CH2-NH) Scan of Peptide YY (PYY) Active Site, PYY(22−36), for Interaction with Rat Intestinal PYY Receptors: Development of Analogues with Potent in Vivo Activity in the Intestine-Reference-Cited by-同舟云学术

Structure−Activity Studies Including a Ψ(CH2-NH) Scan of Peptide YY (PYY) Active Site, PYY(22−36), for Interaction with Rat Intestinal PYY Receptors: Development of Analogues with Potent in Vivo Activity in the Intestine

Published:2000-08-04 Issue:18 Volume:43 Page:3420-3427
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Balasubramaniam Ambikaipakan¹,Tao Zhiyong¹,Zhai Weixu¹,Stein Meiczyslawa¹,Sheriff Sulaiman¹,Chance William T.¹,Fischer Josef E.¹,Eden Peter E.¹,Taylor John E.¹,Liu Carson D.¹,McFadden David W.¹,Voisin Thierry¹,Roze Claude¹,Laburthe Marc¹

Affiliation:

1. Division of Gastrointestinal Hormones, Department of Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0558, Biomeasure, Inc., 27 Maple Street, Milford, Massachusetts 01757-3650, Department of Surgery, UCLA School of Medicine, Los Angeles, California 90095-6904, and INSERM 410, Faculty of Medicine X, BICHAT, 75870 Paris Cedex, France

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm000052z

Reference45 articles.

1. Peptide YY: A neuropeptide in the gut. Immunocytochemical and immunochemical evidence

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of peptide YY analogs for the management of type 2 diabetes and obesity;Bioorganic Chemistry;2023-11

2. The Design of a GLP‐1/PYY Dual Acting Agonist;Angewandte Chemie International Edition;2021-03

3. The Design of a GLP‐1/PYY Dual Acting Agonist;Angewandte Chemie;2021-03

4. Engineering of a Potent, Long-Acting NPY2R Agonist for Combination with a GLP-1R Agonist as a Multi-Hormonal Treatment for Obesity;Journal of Medicinal Chemistry;2020-08-26

5. Design of Y2 Receptor Selective and Proteolytically Stable PYY3–36 Analogues;Journal of Medicinal Chemistry;2018-11-06